Generating Plan and Member Savings Through Tailored Pharmacy Benefits

Seeking Customization and Cost Management for a Retiree Population

Kentucky Rural Electric Cooperative (KREC) is a consortium of 13 nonprofit electric utility cooperatives. With a member population that includes retirees on the Medicare Part D prescription drug benefit, KREC wanted to take control of its costs for both the plan and its members by eliminating ancillary expenses that didn’t benefit members. The plan also wanted to tailor its pharmacy benefits to better serve its retiree population and to improve member health through expanded wellness benefits.

To accomplish this, KREC reevaluated its traditional pharmacy benefit manager (PBM) and decided to seek a fully transparent PBM that could develop solutions customized to its population and enable greater cost management. Based on these criteria, KREC selected Navitus as its PBM partner.

Improving Efficiencies with a Medicare Wrap

Prior to Navitus, KREC’s commercial and Medicare populations were served by two separate pharmacy networks and benefit plans, causing confusion and disruption. Retirees used two different PBM benefit cards to pay for their prescriptions and pharmacies had to adjudicate each claim twice, once for each plan.

Working closely with KREC, Navitus designed a wrap solution that applies the same national network to both populations and provided a single-point claim adjudication and plan administration for both the Medicare plan and the commercial plan. Thanks to this change:

  • KREC’s Medicare EGWP plan benefited from Navitus’ full pass-through model, receiving all rebates, coverage gap discounts and subsidies from CMS
  • Pharmacies could now process claims with a single adjudication for both the commercial plan and Medicare plan, ensuring that eligible claims were processed through Medicare Part D first
  • Retirees gained the convenience of using only one card and peace of mind knowing that they would receive all of their benefits from both plans

Implementing a Vaccination Program

To improve member health, KREC implemented a vaccination program that enabled members to conveniently receive vaccines at any pharmacy in the Navitus National Network. Covering vaccines for influenza, pneumonia, tetanus, hepatitis, meningitis, shingles, HPV and varicella, the program encouraged member participation by removing roadblocks to accessibility.

Reducing Costs Through Formulary Management

In addition to a self-funded Medicare wrap, Navitus identified a second cost reduction opportunity in KREC’s formulary management. Instead of a common formulary that prioritized rebated above all else, Navitus enabled KREC to switch to a well-managed formulary that prioritized the lowest net cost without compromising access to clinically-effective medications. This formulary was then paired with a comprehensive suite of utilization management tools, including prior authorization, step therapy and quantity limits.

Reducing Costs Through Formulary Management

In addition to a self-funded Medicare wrap, Navitus identified a second cost reduction opportunity in KREC’s formulary management. Instead of a common formulary that prioritized rebated above all else, Navitus enabled KREC to switch to a well-managed formulary that prioritized the lowest net cost without compromising access to clinically-effective medications. This formulary was then paired with a comprehensive suite of utilization management tools, including prior authorization, step therapy and quantity limits.

Realizing Plan and Member Savings

  • $1.3 million in first-year savings, a 29% reduction compared to the previous year
  • A 24.6% decrease in per member per month (PMPM) costs in the first year to $70.99
  • A 13% increase in generic utilization in the first two years

These savings benefited not only the plan, but also its members: The average first-year member cost share was only 18.4%. In contrast, the average cost share is 30% for family coverage and 18% for single coverage1. KREC’s results are especially impressive given that cost share is typically higher for older members and smaller organizations1.

Getting Started

Are you interested in exploring how a truly transparent, pass-through model could lower your plan spend? Contact us at [email protected] to learn more.

1 Claxton G, Rae M, Damico A, et al. Employer Health Benefits: 2019 Annual Survey. Kaiser Family Foundation. https://www.kff.org/health-costs/report/2019-employer-health-benefits-survey/. Published September 25, 2019. Accessed October 11, 2019.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Navigating with a trusted partner

Now Available: 9th Annual Drug Trend Report

Our Drug Trend Report provides a clear view of the trends shaping pharmacy benefits today, along with strategies that are delivering real savings without compromising care.

Related blogs

Navigating Healthcare and Improving Outcomes

The Role of Rebates in Pharmacy Benefits

The Role of Rebates in Pharmacy Benefits

In this blog, we’ll break down how rebates work, why they’ve come under increased scrutiny and how transparency — especially from your pharmacy benefit manager (PBM) — can help your organization truly lower prescription drug costs. …

PBM 101: Understanding Spread Pricing and Its Impact on Plan Costs 

PBM 101: Understanding Spread Pricing and Its Impact on Plan Costs 

There is no shortage of questions surrounding pharmacy benefit business models, especially when medication costs continue to rise. One major area of concern centers on a practice that often goes unnoticed or not understood: spread pricing.  …

Part D Star Ratings Adherence Measures: Enabling Strategic and Focused Support for High-risk Beneficiaries Through the Reporting and Intervention for Stars Excellence (RISE) Program

Part D Star Ratings Adherence Measures: Enabling Strategic and Focused Support for High-risk Beneficiaries Through the Reporting and Intervention for Stars Excellence (RISE) Program

Authors: Wenxuan Cai, PharmD, PhD; Amanda Lee, PharmD; Caitlin Albrecht, PharmD; Maria Basak, CPhT; Casey Herlache; Capriana Hadel, MBA Executive Summary Adherence to key medication classes is a critical metric for evaluating health plan quality and continuous…

PBM 101: How to Evaluate Your PBM

PBM 101: How to Evaluate Your PBM

Choosing a pharmacy benefit manager (PBM) isn’t just about managing prescription drug costs – it’s about ensuring your PBM operates in a way that aligns with your financial, operational and philosophical goals. A truly aligned PBM works toward the same…

Introducing NavitusClear with Costco® Cost Plus Model

Introducing NavitusClear with Costco® Cost Plus Model

NavitusClear is our designation awarded to partners that exemplify the level of transparency in drug pricing we believe should be the industry norm. This solution reflects the shared commitment between Navitus and Costco to address rising drug costs…

PBM 101: Understanding Transparency for Better Pharmacy Benefits

PBM 101: Understanding Transparency for Better Pharmacy Benefits

When it comes to pharmacy benefit managers (PBMs), the word “transparency” gets thrown around a lot. It’s frequently promised, widely discussed and inconsistently delivered.  …

Legal Ease: Key Legislative & Regulatory Updates Impacting Plan Sponsors in 2025

Legal Ease: Key Legislative & Regulatory Updates Impacting Plan Sponsors in 2025

In this overview of our national Legal Ease webinar event, we highlight key federal and state developments shaping the conversation around PBM reform – and what they mean for your clients.  …

Navigating the Drug Supply Chain: What You Need to Know

Navigating the Drug Supply Chain: What You Need to Know

Before a prescription ever reaches a pharmacy counter, it has already moved through a complex ecosystem known as the drug supply chain. From manufacturers and wholesalers to pharmacy benefit managers (PBMs) and pharmacies, each entity plays a role in…

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

previous arrow
next arrow